Truist Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$143M Sell
407,214
-27,087
-6% -$9.66M 0.19% 104
2025
Q4
$142M Sell
434,301
-37,080
-8% -$11.8M 0.19% 103
2025
Q3
$133M Sell
471,381
-157,935
-25% -$45.8M 0.18% 111
2025
Q2
$176M Sell
629,316
-16,871
-3% -$4.78M 0.26% 81
2025
Q1
$201M Sell
646,187
-2,208
-0.3% -$652K 0.32% 62
2024
Q4
$169M Sell
648,395
-11,883
-2% -$3.53M 0.26% 71
2024
Q3
$213M Sell
660,278
-25,670
-4% -$8.4M 0.33% 57
2024
Q2
$214M Buy
685,948
+51,795
+8% +$15.2M 0.33% 59
2024
Q1
$180M Sell
634,153
-36,789
-5% -$10.8M 0.27% 78
2023
Q4
$193M Sell
670,942
-90,913
-12% -$24.8M 0.31% 72
2023
Q3
$205M Buy
761,855
+26,917
+4% +$6.72M 0.34% 65
2023
Q2
$163M Sell
734,938
-88,775
-11% -$20.6M 0.27% 85
2023
Q1
$199M Buy
823,713
+6,134
+0.8% +$1.51M 0.34% 65
2022
Q4
$215M Sell
817,579
-47,111
-5% -$12.6M 0.38% 62
2022
Q3
$195M Buy
864,690
+18,512
+2% +$4.49M 0.37% 66
2022
Q2
$206M Buy
846,178
+2,099
+0.2% +$514K 0.38% 62
2022
Q1
$204M Buy
844,079
+41,535
+5% +$9.54M 0.32% 78
2021
Q4
$181M Sell
802,544
-10,461
-1% -$2.21M 0.28% 84
2021
Q3
$173M Buy
813,005
+7,123
+0.9% +$1.64M 0.28% 83
2021
Q2
$196M Sell
805,882
-7,531
-0.9% -$1.85M 0.32% 77
2021
Q1
$202M Sell
813,413
-17,314
-2% -$4.13M 0.35% 69
2020
Q4
$191M Buy
830,727
+6,661
+0.8% +$1.54M 0.37% 64
2020
Q3
$209M Sell
824,066
-45,637
-5% -$11.3M 0.46% 47
2020
Q2
$205M Sell
869,703
-12,467
-1% -$2.84M 0.46% 49
2020
Q1
$179M Buy
882,170
+11,507
+1% +$2.51M 0.47% 49
2019
Q4
$210M Buy
870,663
+763,329
+711% +$168M 0.43% 53
2019
Q3
$20.8M Sell
107,334
-1,951
-2% -$374K 0.36% 70
2019
Q2
$20.1M Buy
109,285
+1,223
+1% +$219K 0.35% 72
2019
Q1
$20.5M Buy
108,062
+2,529
+2% +$483K 0.37% 70
2018
Q4
$20.5M Buy
105,533
+3,764
+4% +$734K 0.42% 57
2018
Q3
$21.1M Buy
101,769
+2,271
+2% +$448K 0.38% 62
2018
Q2
$18.4M Sell
99,498
-101
-0.1% -$17.9K 0.35% 76
2018
Q1
$17M Buy
99,599
+7,194
+8% +$1.32M 0.32% 81
2017
Q4
$16.1M Buy
92,405
+294
+0.3% +$52K 0.3% 89
2017
Q3
$17.2M Buy
92,111
+4,863
+6% +$862K 0.33% 78
2017
Q2
$15M Buy
87,248
+4,627
+6% +$753K 0.3% 93
2017
Q1
$13.6M Sell
82,621
-2,261
-3% -$376K 0.27% 104
2016
Q4
$12.4M Buy
84,882
+832
+1% +$125K 0.25% 109
2016
Q3
$14M Buy
84,050
+3,124
+4% +$528K 0.29% 98
2016
Q2
$12.3M Buy
80,926
+29,248
+57% +$4.55M 0.26% 110
2016
Q1
$7.75M Buy
51,678
+6,215
+14% +$923K 0.2% 130
2015
Q4
$7.38M Buy
45,463
+8,846
+24% +$1.39M 0.19% 144
2015
Q3
$5.06M Buy
36,617
+15,862
+76% +$2.5M 0.13% 187
2015
Q2
$3.19M Buy
20,755
+922
+5% +$148K 0.09% 239
2015
Q1
$3.17M Buy
19,833
+1,057
+6% +$166K 0.09% 231
2014
Q4
$2.99M Buy
18,776
+165
+0.9% +$25.7K 0.09% 229
2014
Q3
$2.61M Buy
18,611
+261
+1% +$34.1K 0.08% 243
2014
Q2
$2.17M Buy
18,350
+358
+2% +$41.4K 0.07% 268
2014
Q1
$2.22M Buy
17,992
+1,497
+9% +$182K 0.07% 263
2013
Q4
$1.88M Buy
16,495
+6,130
+59% +$697K 0.06% 278
2013
Q3
$1.16M Buy
10,365
+713
+7% +$77.3K 0.04% 320
2013
Q2
$953K Buy
+9,652
New +$1M 0.04% 334

Other funds holding AMGN

Truist Financial's AMGN Position: Q1 2026 in Review

Truist Financial reduced its Amgen (AMGN) stake by 6.2% in Q1 2026, selling an estimated $9.66M and leaving 407,214 shares worth $143M. The position accounts for 0.19% of the portfolio, ranked #104.

Truist Financial first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $215M in Q4 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Truist Financial held 407,214 shares of Amgen worth $143M as of Q1 2026.
  • Truist Financial sold 27,087 Amgen shares in Q1 2026, an estimated $9.66M.
  • Amgen made up 0.19% of Truist Financial's portfolio in Q1 2026, its #104 holding.
  • Truist Financial first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Truist Financial's Amgen position peaked at $215M in Q4 2022.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.